Prof. Dr. Said Desouky | Biomaterials | Best Researcher Award

Kyushu University | Japan

Prof. Dr. Said E. Desouky is a distinguished Professor of Microbial Biotechnology at the Faculty of Science, Al-Azhar University, Egypt, and a recognized international researcher with extensive academic and scientific achievements in the fields of microbiology, microbial communication, and antibiotic resistance. He earned his Ph.D. in Bioscience and Biotechnology from Kyushu University, Japan, after completing his M.Sc. and B.Sc. in Microbiology from Al-Azhar University. His research focuses on microbial biotechnology, biopolymer production, quorum sensing inhibition, and bioconversion processes for environmental and industrial applications. With an h-index of 15, 27 publications, and 653 citations derived from 588 documents, Prof. Desouky’s work has contributed significantly to advancing microbial physiology, sustainable bioprocessing, and bioengineering. He has received multiple fellowships and research grants, including the Fulbright Fellowship at Texas A&M University (USA), fellowships from JASSO and Kyushu University (Japan), and grants from the Science and Technology Development Fund (Egypt) and the European Union’s Erasmus+ Program. His collaborations extend across global institutions, leading international projects focused on climate change adaptation, microbial innovations, and biotechnological solutions for waste management. Prof. Desouky has supervised more than twenty M.Sc. and Ph.D. candidates, served as an examiner for international dissertations, and contributed to scientific innovation recognized at the Geneva International Exhibition, where his team won a silver medal. Beyond research, he is deeply involved in academic leadership, serving as Director of the Quality Assurance Unit and as a capacity-building expert for higher education programs under UNDP initiatives. His academic excellence, leadership in biotechnology education, and impactful research on microbial sustainability make him a leading figure in microbiological sciences and an outstanding candidate for the Best Researcher Award for his remarkable contributions to global scientific and technological advancement.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Jabborova, D., Wirth, S., Kannepalli, A., Narimanov, A., Desouky, S., et al. (2020). Co-inoculation of rhizobacteria and biochar application improves growth and nutrients in soybean and enriches soil nutrients and enzymes. Agronomy, 10(8), 1142.

Jabborova, D., Annapurna, K., Paul, S., Kumar, S., Saad, H. A., Desouky, S., et al. (2021). Beneficial features of biochar and arbuscular mycorrhiza for improving spinach plant growth, root morphological traits, physiological properties, and soil enzymatic activities. Journal of Fungi, 7(7), 571.

Ibrahim, S. A., Fayed, E. A., Rizk, H. F., Desouky, S. E., & Ragab, A. (2021). Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies. Bioorganic Chemistry, 112, 105339.

Desouky, S. E., Shojima, A., Singh, R. P., Matsufuji, T., Igarashi, Y., Suzuki, T., et al. (2015). Cyclodepsipeptides produced by actinomycetes inhibit cyclic-peptide-mediated quorum sensing in Gram-positive bacteria. FEMS Microbiology Letters, 362(14), fnv109.

Jabborova, D., Davranov, K., Jabbarov, Z., Bhowmik, S. N., Ercisli, S., Danish, S., Desouky, S., et al. (2022). Dual inoculation of plant growth-promoting Bacillus endophyticus and Funneliformis mosseae improves plant growth and soil properties in ginger. ACS Omega, 7(39), 34779–34788.

Assoc. Prof. Dr. Ashwin Jagannath Mali | Biomaterials | Biomaterials Excellence

Poona College of Pharmacy Pune | India

Assoc. Prof. Dr. Ashwin Jagannath Mali is an accomplished pharmaceutical scientist and academic leader currently serving as the Head of the Department of Industrial Pharmacy at Bharati Vidyapeeth (Deemed to be) University, Poona College of Pharmacy, Pune, India. With over 18 years of academic and research experience, he has made significant contributions to the fields of pharmaceutics, particle engineering, and drug delivery systems. Dr. Mali’s research primarily focuses on the design and development of innovative dosage forms, including dry powder inhalers, micellar systems, and nanocarriers for enhanced therapeutic efficacy. He has authored 21 scientific publications, received 180 citations from 151 documents, and holds an h-index of 8, reflecting his growing influence in the pharmaceutical sciences community. His contributions extend beyond publications to include patents, book chapters, and numerous presentations at international and national conferences. He has successfully led and collaborated on multiple funded research and industrial consultancy projects, fostering translational outcomes between academia and pharmaceutical industries. Under his mentorship, several postgraduate and doctoral students have undertaken impactful research contributing to advancements in drug formulation and delivery. Known for his commitment to academic excellence and innovation, Dr. Mali actively promotes research-based learning and industry collaboration. His efforts in bridging the gap between fundamental pharmaceutical research and applied industrial practices have positioned him as a thought leader in his domain. A dedicated educator and innovator, Assoc. Prof. Dr. Ashwin Jagannath Mali continues to drive progress in pharmaceutical technology, ensuring that his research translates into real-world health benefits, thereby strengthening his reputation as one of the leading contributors to modern drug delivery science in India and beyond.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Kumbhar, S., Bobade, C., Velapure, P., Pawade, D., Bothiraja, C., Shinde, V., & Mali, A. (2025). Exploring the albumin nanoparticles as the next-generation advanced multifunctional biomaterials for inhalation lung therapy: Facts, prospects, and challenges. Biomedical Materials & Devices.

Panda, B. K., Bothiraja, C., Ghodke, S., Mali, A., & Kamble, R. (2024). Investigation of magnesium aluminometasilicate (Neusilin US2) based surface solid dispersion of sorafenib tosylate using QbD approach: In vitro and in vivo pharmacokinetic study. ADMET and DMPK, 12(3), 2338.

Kamble, R. N., Kausar, E., Kawadiwale, M. S., & Mali, A. J. (2023). Development and characterization of linezolid-loaded biocompatible solid lipid-based nanocarrier for enhanced lung deposition and anti-tubercular activity: Next-generation tailor-made carrier for dry powder inhaler. Current Indian Science, 3(8), 103042.

Bothiraja, C., Kashid, S., Pawar, A., & Mali, A. (2022). Investigation of dimyristoyl phosphatidyl glycerol and cholesterol-based nanocochleates as a potential oral delivery carrier for methotrexate. Journal of Liposome Research, 32(5), 402–412.

Mali, A. J., Joshi, P. A., Bothiraja, C., & Pawar, A. P. (2021). Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery. Future Journal of Pharmaceutical Sciences, 7, 189.

Patel, K., Bothiraja, C., Mali, A., & Kamble, R. (2021). Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer. Particulate Science and Technology, 39(8), 1016–1026.

Prof. Probal Banerjee | Biomaterials | Best Researcher Award

The College of Staten Island City University of New York | United States

Prof. Probal Banerjee is a distinguished academic and accomplished scientist whose extensive contributions to biochemical and molecular research have established him as a leading figure in his field. With an impressive record of 95 published documents, his work has garnered 4,636 citations across 3,799 documents, reflecting his strong influence and consistent impact in scientific research. He holds an outstanding h-index of 40, underscoring both the depth and the longevity of his scholarly influence. Prof. Banerjee’s research encompasses molecular biology, neurochemistry, and pharmacological sciences, contributing significantly to understanding cellular mechanisms and biochemical pathways relevant to human health and disease. He is recognized not only for his pioneering studies but also for his mentorship, having guided numerous students and researchers who now contribute globally to science and medicine. His publications are featured in reputed international journals, and his research excellence is evidenced by his ability to integrate innovative methodologies and interdisciplinary approaches. Throughout his academic journey, Prof. Banerjee has demonstrated a rare combination of scientific rigor, creativity, and leadership, earning respect from peers worldwide. His commitment to advancing biochemical research and fostering young scientific talent has solidified his position as a thought leader in his domain. Through continuous contributions to scientific innovation and education, Prof. Banerjee remains dedicated to pushing the boundaries of modern molecular and biomedical sciences, making him a valuable asset to the global scientific community.

Profiles: Scopus | Orcid

Featured Publications

Molecules (Basel, Switzerland). (2025). One-pot synthesis of phenylboronic acid-based microgels for tunable gate of glucose-responsive insulin release at physiological pH. Molecules.

Gels. (2023). Biocompatible anisole-nonlinear PEG core–shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels.

Geroscience. (2025). Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension. Geroscience.

PNAS Nexus. (2025). Targeting sickle cell pathobiology and pain with novel transdermal curcumin. PNAS Nexus.

The G protein-coupled serotonin 1A receptor augments protein kinase Cε-mediated neurogenesis in neonatal mouse hippocampus—PKCε-mediated signaling in the early hippocampus. (2022). International Journal of Molecular Sciences, 23(24).

Dr. Fazle Kibria | Biomaterials | Best Researcher Award

Lovelace Biomedical Research Institute | United States

Dr. Fazle Kibria is a highly skilled biomedical engineer and postdoctoral scholar at the Lovelace Biomedical Research Institute, USA, specializing in photonics-based neuromodulation and implantable device design for traumatic brain injury treatment. With a Ph.D. in Biomedical Engineering from Jadavpur University, he has established himself as a promising researcher in neuroengineering, optical fiber sensors, and biomedical device innovation. Dr. Kibria has authored 4 scientific papers, attracting 16 citations from 16 documents, and holds an h-index of 2, reflecting the growing impact of his research in the fields of photobiomodulation, neurotherapy, and medical device development. His professional experience spans prestigious institutions such as the University of South Florida, Case Western Reserve University, and the Department of Health & Family Welfare, Government of West Bengal, India, where he contributed to medical technology implementation and healthcare infrastructure. His research focuses on developing advanced optical fiber probes, polymer-based biosensors, and piezoelectric nanofiber devices for non-invasive diagnostics and neurocardiac analysis. He has received the Gandhian Young Technological Innovation Award, among others, for his pioneering work in fabricating nano-probes and biomedical sensors. A member of SPIE, the American Heart Association, and the Indian Science Congress Association, Dr. Kibria is committed to merging engineering and medicine to develop next-generation biomedical technologies for brain and cardiac health, contributing meaningfully to the global medical research community.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Cáceres, F. K. A. A. D. E., Salazar, P., Shidoh, S., Ortiz, M. J., & Denis, E. (2025). Noninvasive vagus nerve stimulation protects neurons in the perihematomal region and improves the outcomes in a rat model of intracerebral hemorrhage. Neurocritical Care, 4.

Patra, F. K. S. N. (2018). Fabrication of fiber-aided nano device for minimally invasive photonics-based sub-micron level lesion detection and interventional treatment. International Journal for Research in Engineering Application & Management, 2.

Kibria, F. A. O. T. D. B., & Bragina, O. A. (2025). Bidirectional interplay between traumatic brain injury and cardiovascular dysfunction in athletes. Journal of Clinical Medicine, 14(21), 7712.

Bragin, D., Kibria, F., Bragina, O., Trofimov, A., Kalinkina, E., Volkova, E., et al. (2025). Photobiomodulation in the treatment of acute traumatic brain injury. Critical Care Medicine, 53(1).

Kibria, F., Das, S. K., & Arefin, M. S. (2024). The role of nicotinamide adenine dinucleotide salvage enzymes in cardioprotection. Polish Journal of Thoracic and Cardiovascular Surgery, 21(2), 86–95.

Dr. DuJiang Yang | Biomaterials | Best Researcher Award

The Affiliated Traditional Chinese Medicine Hospital | Southwest Medical University | China

Dr. DuJiang Yang is an emerging medical researcher and clinician specializing in traditional Chinese orthopedics, with a strong focus on molecular mechanisms of bone and joint disorders. Currently pursuing his master’s degree in Orthopedic Traditional Chinese Medicine at Southwest Medical University, Dr. Yang has already established an impressive research record for his age. He has published 13 SCI-indexed papers as the first author, with an h-index of 1, 13 total publications, and 3 citations recorded across 3 cited documents. His research spans areas including osteoarthritis, spinal cord injury, and immunopathology, with multiple contributions in prestigious journals such as Leukemia, Angiogenesis, Biofabrication, Journal of Translational Medicine, and Diabetes/Metabolism Research and Reviews. His cumulative impact factor exceeds 120, reflecting the international recognition of his scientific quality. Dr. Yang’s studies often bridge traditional medicine and advanced biomedical technologies such as single-cell analysis, spatial transcriptomics, and molecular docking, aiming to decode therapeutic mechanisms of herbal formulations in musculoskeletal regeneration. In addition to research, he actively participates in clinical training at the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, where he applies his translational insights to patient care. His early achievements have earned him numerous awards, including multiple “Excellent Student” and “Outstanding Youth” recognitions, highlighting his leadership and scholarly promise. Technically proficient in molecular biology methods and statistical software, Dr. Yang demonstrates exceptional capability in both bench and clinical research environments. With an expanding international publication record, he stands as a young yet influential voice in translational orthopedics, committed to advancing evidence-based approaches that integrate traditional medicine with modern molecular science.

Profile: Scopus

Featured Publications

Yang, D. J., Gong, G. W., Song, J. F., Li, J. C., Chen, J. J., & Wang, G. Y. (2025). Ferroptosis-mediated osteoclast–osteoblast crosstalk: Signaling pathways governing bone remodeling in osteoporosis. Journal of Orthopaedic Surgery and Research, [Q3, IF = 2.8].

Yang, D. J., Liu, Q., Tang, X. X., Chen, J., Wang, S., Gong, G., & Wang, G. Y. (2025). Letter to the editor regarding: Bio-3D printing of scaffold-free ADSC-derived cartilage constructs comparable to natural cartilage in vitro. Journal of Orthopaedic Surgery and Research, [Q3, IF = 2.8].

Lu, J., Yang, D. J., Lai, C., & Wang, G. Y. (2025). Letter to the editor regarding: SIRT3 alleviates mitochondrial dysfunction and senescence in diabetes-associated periodontitis by deacetylating LRPPRC. Aging and Disease, [Q2, IF = 6.9].

Chen, J. J., Yang, D. J., He, J. Y., Yuan, X. T., Liu, Y. Q., Yang, J. X., Wang, G. Y., Peng, T., & Shen, H. R. (2025). Polygonatum polysaccharide induces tenocyte stem cell differentiation into chondrocytes through the TGF-β3/SMAD2 signaling pathway. Chinese Journal of Clinical Pharmacology and Therapeutics, 30(7), 1010. [Peking University Core Journal].

Yang, W., Ma, G., Li, J., Guan, T., He, D., Yang, D., Wang, G., & Shi, H. (2025). Anxiety and depression as potential risk factors for limited pain management in elderly patients with knee osteoarthritis: A cross-lagged study. [Journal Name] [SCI Q2, IF = 3.3].

Prof. Dr. Zine El Abidine Chaoui | Biomaterials | Best Researcher Award

Setif 1 University Ferhat Abbas | Algeria

Prof. Dr. Zine El Abidine Chaoui is a distinguished physicist and academic leader serving at the University of Setif 1, Algeria, where he holds a permanent position in the Department of Physics. With an exceptional academic and research career spanning over two decades, he has made significant contributions to radiation physics, dosimetry, radiotherapy, and radiobiology. He currently leads the Optoelectronics and Devices Laboratory and coordinates the Medical Physics Master’s program, where he also oversees a high-performance computing platform for advanced simulation research. Prof. Chaoui has authored 26 peer-reviewed publications, accumulated 321 citations from 243 documents, and holds an h-index of 10, reflecting the lasting impact of his scientific work. His research includes groundbreaking studies on Monte Carlo simulations for radiation transport, radiobiological modeling for treatment optimization, and dosimetric evaluations of cancer therapy techniques such as IMRT and VMAT. His articles have appeared in leading international journals including Applied Radiation and Isotopes, Journal of Instrumentation, Surface and Interface Analysis, and Physics Letters A. Beyond his research, Prof. Chaoui has supervised numerous Ph.D. and Master’s theses, fostering the next generation of medical physicists in Algeria. His international collaborations span esteemed institutions such as the University of Trento, University of Birmingham, Swansea University, and PTB Braunschweig, enhancing his global research footprint. A recognized expert in radiation physics education and research, Prof. Chaoui has contributed extensively to improving radiotherapy accuracy and safety. His pioneering efforts in simulation and radiobiology continue to influence modern cancer treatment methodologies. Through his scientific rigor, mentorship, and leadership, Prof. Dr. Zine El Abidine Chaoui exemplifies excellence in the fields of radiation physics and medical dosimetry.

Profiles: Orcid | Scopus

Featured Publications

Chaoui, Z.-E.-A. (2025). New radiobiological comparison of intensity-modulated radiation therapy prostate plans of seven and five fields. International Journal of Radiation Research.

Chaoui, Z.-E.-A. (2022). Dosimetric beam matching analysis of MV photons and electrons therapy. International Journal of Radiation Research, 20(3), 25–35.

Chaoui, Z.-E.-A. (2021). PENELOPE simulations and experiment for 6 MV Clinac iX accelerator for standard and small static fields. Applied Radiation and Isotopes, 178, 109749.

Aker, M., Altenmüller, K., Amsbaugh, J. F., Arenz, M., Babutzka, M., Bast, J., Bauer, S., Bechtler, H., Beck, M., Beglarian, A., et al. (2021). The design, construction, and commissioning of the KATRIN experiment. Journal of Instrumentation, 16(08), T08015.

Aouina, N. Y., & Chaoui, Z.-E.-A. (2018). Electrons and positrons elastic collisions with pyrimidine and tetrahydrofuran. Applied Radiation and Isotopes, 140, 197–203.

Mr. Kunal Pal | Biomaterials | Young Scientist Award

Mr. Kunal Pal | Jadavpur University | India

Mr. Kunal Pal is an emerging biomedical researcher with strong expertise in nanomedicine, molecular biology, and cancer therapeutics. With 64 published documents, 1,326 total citations from 1,177 referencing documents, and an h-index of 20, his research contributions reflect high academic quality and influence. He has conducted pioneering work in developing nanoparticle-based delivery systems, particularly focusing on biocompatible and green nanomaterials for targeted cancer therapy. His doctoral research at Bose Institute explored curcumin delivery systems for triple-negative breast cancer, showcasing innovation in molecular design and therapeutic efficacy. Mr. Pal’s studies integrate multidisciplinary approaches encompassing toxicology, bioimaging, nanotechnology, and drug delivery mechanisms, resulting in publications in reputed journals such as Inorganic Chemistry, Dalton Transactions, Materials Science and Engineering: C, and Nanomedicine. He has also presented his research at multiple international conferences and received honors including the Young Researcher Award from the National Environmental Science Academy. Beyond academia, he has served as a scientific advisor in industry and reviewer for leading journals like Scientific Reports and Apoptosis, demonstrating his versatility and leadership in translational science. His commitment to bridging molecular research with therapeutic applications positions him as a forward-looking scientist contributing to the advancement of biomedical innovation and sustainable nanotechnology in cancer treatment.

Profiles: Scopus | Google Scholar

Featured Publications

Gautam, A., Ray, A., Mukherjee, S., Das, S., Pal, K., Das, S., Karmakar, P., Ray, M., et al. (2018). Immunotoxicity of copper nanoparticle and copper sulfate in a common Indian earthworm. Ecotoxicology and Environmental Safety, 148, 620–631.

Laha, D., Pal, K., Chowdhuri, A. R., Parida, P. K., Sahu, S. K., Jana, K., & Karmakar, P. (2019). Fabrication of curcumin-loaded folic acid-tagged metal-organic framework for triple negative breast cancer therapy in in vitro and in vivo systems. New Journal of Chemistry, 43(1), 217–229.

Roy, S. D. S., Bardhan, S., Pal, K., Ghosh, S., Mandal, P., et al. (2018). Crystallinity mediated variation in optical and electrical properties of hydrothermally synthesized boehmite (γ-AlOOH) nanoparticles. Journal of Alloys and Compounds, 763, 749–758.

Banerjee, S., Bagchi, B., Bhandary, S., Kool, A., Hoque, N. A., Biswas, P., Pal, K., et al. (2018). Antimicrobial and biocompatible fluorescent hydroxyapatite-chitosan nanocomposite films for biomedical applications. Colloids and Surfaces B: Biointerfaces, 171, 300–307.

Ghorai, P., Pal, K., Karmakar, P., & Saha, A. (2020). The development of two fluorescent chemosensors for the selective detection of Zn²⁺ and Al³⁺ ions in a quinoline platform by tuning the substituents in the receptor part. Dalton Transactions, 49(15), 4758–4773.

Assoc. Prof. Dr. Suray Pehlivanoglu | Biomaterials | Best Researcher Award

Assoc. Prof. Dr. Suray Pehlivanoglu | Necmettin Erbakan University | Turkey

Assoc. Prof. Dr. Suray Pehlivanoğlu is a distinguished molecular biologist and geneticist serving at Necmettin Erbakan University, Faculty of Science, Department of Molecular Biology and Genetics, Meram, Konya, Turkey. He holds a Ph.D. in Medical Genetics from Akdeniz University, where his doctoral work focused on TWIST1 transcription factor activation mechanisms and natural inhibitors, building upon his earlier master’s research on FGFR2 gene mutations in craniosynostosis. Dr. Pehlivanoğlu’s academic career spans over a decade, progressing from Research Assistant at Akdeniz University to Assistant Professor and now Associate Professor, where he supervises master’s and doctoral theses in cancer biology, immunogenetics, and molecular signaling. His research emphasizes cancer molecular biology, transcription factor regulation, hypoxia signaling, PAK4-mediated pathways, nanoparticle-based therapeutics, and regenerative medicine, with contributions to the development of novel anticancer agents and nanomaterials with targeted cytotoxic effects. He has been principal investigator and collaborator on numerous nationally funded projects, including studies on platelet-derived growth factor signaling, TWIST1 target gene transcriptomics, and biosynthesis of anticancer nanomaterials. Dr. Pehlivanoğlu has authored 35 peer-reviewed documents, accumulating 254 citations from 243 publications and maintaining an h-index of 10, reflecting the impact and consistency of his scientific contributions. He has published widely in international journals such as Molecular and Cellular Endocrinology, Journal of Cellular and Molecular Medicine, and 3 Biotech, and contributed chapters to scientific books on neuroplasticity, craniosynostosis, and stem cell applications. His innovative work has earned several honors, including oral presentation awards and recognition for excellence in cancer biology research. Actively engaged in mentoring young researchers, he continues to explore molecular mechanisms of tumor progression, hypoxia response, and immune modulation, aiming to translate his findings into novel therapeutic strategies and clinical applications.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Sarigüney, B., Karakaş Sarikaya, E., & Pehlivanoğlu, S. (2024). Determining stable structure and in vitro antiproliferative properties of a novel 3-(2-((4-trifluoromethyl)phenyl)amino)thiazol-4-yl)-2H-chromen-2-one molecule. Chemistry & Biodiversity.

Acar, C. A., Gencer, M. A., Pehlivanoglu, S., Yesilot, S., & Donmez, S. (2024). Green and eco-friendly biosynthesis of zinc oxide nanoparticles using Calendula officinalis flower extract: Wound healing potential and antioxidant activity. International Wound Journal.

Acar, C. A., Pehlivanoglu, S., Yesilot, S., & Yakut Uzuner, S. (2023). Microwave-assisted biofabrication of silver nanoparticles using Helichrysum arenarium flower extract: Characterization and biomedical applications. Biomass Conversion and Biorefinery.

Findik, M., Türkkan, E., Pehlivanoglu, S., Sayin, U., Ceylan, U., & Akgemci, E. G. (2023). New copper(II) complex based-thiosemicarbazone and phenanthroline: DNA/BSA binding, antiproliferative activity, DFT and docking studies. Inorganic Chemistry Communications, 154, 111300.

Findik, M., Kuzu, B., Pehlivanoglu, S., Kaya, S., Sayin, U., Guler Akgemci, E., & Saf, A. O. (2023). Synthesis of carbazole-substituted thiosemicarbazone and its Cu(II) complex, DNA/protein binding, cytotoxic, antiproliferative activities and molecular docking studies. Inorganic Chemistry Communications, 152, 110711.

Dr. Baozhe Jin | Biomaterials | Best Researcher Award

Dr. Baozhe Jin is a highly respected Chief Physician of Neurosurgery at The First Affiliated Hospital of Xinxiang Medical University, China. He is dedicated to advancing both clinical and basic research in neural injury, protection, and functional repair. With extensive experience in skull base microanatomy and nerve regeneration medicine, he contributes to critical breakthroughs in neurotrauma management. His ongoing projects focus on gene-modified therapies and neuroprotective strategies, highlighting his deep commitment to improving patient outcomes through innovation.

Dr. Baozhe Jin | The First Affiliated Hospital of Xinxiang Medical University | China

Profile

SCOPUS

Education

Dr. Jin possesses a robust medical and academic background, leading him to become a chief physician and researcher in the specialized field of neurofunctional repair. Though the exact educational milestones are not detailed, his clinical authority and ongoing research roles reflect a rigorous and accomplished academic journey. He actively collaborates with leading neurosurgery centers such as Beijing Tiantan Hospital and serves as a member of the Neurocontrol Professional Committee of the Chinese Medical Doctor Association, reinforcing his scientific credibility.

Experience

Dr. Jin has led major neuroprotective research initiatives, notably the Henan Medical Science and Technology Key Project investigating valproic acid combined with NT-3 gene-modified olfactory sheath cells for treating traumatic brain injury. This study blends clinical insight with cutting-edge biomedical engineering. Additionally, he participates in key scientific and technological research projects sponsored by Henan Province, focusing on improving post-injury neural outcomes.

Contributions

Dr. Baozhe Jin has demonstrated long-term dedication to advancing neural function repair and protection following traumatic brain injury (TBI). His research bridges skull base microanatomy, clinical neurosurgical applications, and regenerative neuroscience, focusing on developing innovative treatments such as gene-modified olfactory ensheathing cells and neuroprotective compounds. He combines clinical expertise with cutting-edge biomedical research to improve outcomes in patients with central nervous system injuries. His work contributes to the growing field of nerve regeneration medicine, making strides in both basic science and translational clinical applications

Research Focus 

Dr. Jin’s research targets functional protection and repair following central nervous system injuries, including traumatic brain injury and spinal cord damage. His interdisciplinary approach bridges clinical neurosurgery, molecular neuropharmacology, and regenerative medicine, focusing on gene therapies, olfactory ensheathing cells, and pharmaceutical interventions like valproic acid. His contributions improve both the understanding and treatment of neural trauma.

Publications

Effect of Dynamin-2 Gene Modified OECs on Functional and Molecular Neuroprotection After Spinal Cord Injury in Rats
Journal: Neurochemical Research, 2025

Expression of Homeobox Gene-A7 in Glioma and Its Effect on Proliferation and Apoptosis of Glioma Cells
Journal: Journal of Xinxiang Medical University, 2024

Effect of Valproic Acid Combined with Transplantation of Olfactory Ensheathing Cells Modified by Neurotrophic 3 Gene on Nerve Protection and Repair After Traumatic Brain Injury
Journal: Neuropeptides, 2024

Conclusion

Dr. Baozhe Jin is a dedicated clinician-scientist with impactful research contributions in neural repair and regeneration. His work bridges basic neuroscience with clinical application, reflecting a strong foundation for innovation in the treatment of brain injuries. He is a deserving candidate for the Best Researcher Award, and with expanded academic outreach and global engagement, his influence in the field is likely to grow further.